Initial experience with the novel p64MW HPC flow diverter from a cohort study in unruptured anterior circulation aneurysms under dual antiplatelet medication.
Andrey PetrovGanbaatar RentsenkhuBaatarjan NotaErdenebat GanzorigBoldbat RegzengomboSara JaguschElina HenkesHans HenkesPublished in: Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences (2020)
p64MW HPC implantation in patients under dual antiplatelet therapy with or without dual platelet function inhibition has a low procedural complication rate. The early aneurysm occlusion rate is high.
Keyphrases
- antiplatelet therapy
- end stage renal disease
- acute coronary syndrome
- ejection fraction
- percutaneous coronary intervention
- newly diagnosed
- internal carotid artery
- chronic kidney disease
- healthcare
- coronary artery
- prognostic factors
- peritoneal dialysis
- emergency department
- coronary artery disease
- abdominal aortic aneurysm